The arginase 1/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury.
The arginase 1/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury.
复制标题
DOI:
10.1038/s41419-023-06147-7
复制
发表时间:
2023-09-21
影响因子:
9
通讯作者:
Fouda, Abdelrahman Y.
中科院分区:
文献类型:
--
作者:
Shosha, Esraa;Shahror, Rami A.;Morris, Carol A.;Xu, Zhimin;Lucas, Rudolf;McGee-Lawrence, Meghan E.;Rusch, Nancy J.;Caldwell, Ruth B.;Fouda, Abdelrahman Y.
The enzyme arginase 1 (A1) hydrolyzes the amino acid arginine to form L-ornithine and urea. Ornithine is further converted to polyamines by the ornithine decarboxylase (ODC) enzyme. We previously reported that deletion of myeloid A1 in mice exacerbates retinal damage after ischemia/reperfusion (IR) injury. Furthermore, treatment with A1 protects against retinal IR injury in wild-type mice. PEG-A1 also mitigates the exaggerated inflammatory response of A1 knockout (KO) macrophages in vitro. Here, we sought to identify the anti-inflammatory pathway that confers macrophage A1-mediated protection against retinal IR injury. Acute elevation of intraocular pressure was used to induce retinal IR injury in mice. A multiplex cytokine assay revealed a marked increase in the inflammatory cytokines interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α) in the retina at day 5 after IR injury. In vitro, blocking the A1/ODC pathway augmented IL-1β and TNF-α production in stimulated macrophages. Furthermore, A1 treatment attenuated the stimulated macrophage metabolic switch to a pro-inflammatory glycolytic phenotype, whereas A1 deletion had the opposite effect. Screening for histone deacetylases (HDACs) which play a role in macrophage inflammatory response showed that A1 deletion or ODC inhibition increased the expression of HDAC3. We further showed the involvement of HDAC3 in the upregulation of TNF-α but not IL-1β in stimulated macrophages deficient in the A1/ODC pathway. Investigating HDAC3 KO macrophages showed a reduced inflammatory response and a less glycolytic phenotype upon stimulation. In vivo, HDAC3 co-localized with microglia/macrophages at day 2 after IR in WT retinas and was further increased in A1-deficient retinas. Collectively, our data provide initial evidence that A1 exerts its anti-inflammatory effect in macrophages via ODC-mediated suppression of HDAC3 and IL-1β. Collectively we propose that interventions that augment the A1/ODC pathway and inhibit HDAC3 may confer therapeutic benefits for the treatment of retinal ischemic diseases.
登录
查看更多内容
影响因子:
5.3
作者:
Fouda, Abdelrahman Y.;Eldahshan, Wael;Xu, Zhimin;Lemtalsi, Tahira;Shosha, Esraa;Zaidi, Syed A. H.;Abdelrahman, Ammar A.;Cheng, Paul Ning-Man;Narayanan, S. Priya;Caldwell, R. William;Caldwell, Ruth B.
通讯作者:
Caldwell, Ruth B.
影响因子:
7.3
作者:
Amici SA;Dong J;Guerau-de-Arellano M
通讯作者:
Guerau-de-Arellano M
影响因子:
4.4
作者:
Berger, Samuel;Savitz, Sean I.;Rosenbaum, Daniel M.
通讯作者:
Rosenbaum, Daniel M.
影响因子:
4.4
作者:
Crosson, Craig E.;Mani, Santhosh K.;Menick, Donald R.
通讯作者:
Menick, Donald R.
影响因子:
2.4
作者:
Frank, Tobias;Schlachetzki, Johannes C. M.;Weishaupt, Jochen H.
通讯作者:
Weishaupt, Jochen H.